SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-057070
Filing Date
2022-05-06
Accepted
2022-05-06 17:22:33
Documents
16
Period of Report
2022-03-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2214400d1_8ka.htm   iXBRL 8-K/A 34148
2 EXHIBIT 23.1 tm2214400d1_ex23-1.htm EX-23.1 2487
3 EXHIBIT 99.1 tm2214400d1_ex99-1.htm EX-99.1 636067
4 EXHIBIT 99.2 tm2214400d1_ex99-2.htm EX-99.2 232540
8 GRAPHIC tm2214400d1_ex99-1img001.jpg GRAPHIC 9496
  Complete submission text file 0001104659-22-057070.txt   1169054

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA syn-20220310.xsd EX-101.SCH 3060
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220310_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220310_pre.xml EX-101.PRE 22614
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2214400d1_8ka_htm.xml XML 3617
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12584 | Film No.: 22902445
SIC: 2834 Pharmaceutical Preparations